Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

INVA

Innoviva, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1080014Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.41B
Net Income FY2025
$0.27B
EPS (Basic, as reported)
$4.02
Net Margin FY2025
65.9%
ROE FY2025
23.1%
Total Equity
$1.17B
Shares Out
72M
Business description

Innoviva, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 134 → 411 +13.3% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue134217261261337392331310359411
Gross profit———————246296308
Research & development(1)(1)00(2)(1)(41)(34)(14)(31)
Selling, general & administrative————(14)(16)(64)(98)(116)(113)
General & administrative(23)(32)(20)(15)(14)(16)————
Total operating expenses(25)(34)(23)(15)(16)(17)(44)(132)(129)(144)
Operating income109184238246321375—114167164
Interest expense(52)(44)(24)(19)(18)(19)(16)(19)(22)(17)
Other income (expense), net2(7)(6)00(4)(3)(5)(3)(3)
Pre-tax income6013421023335444528719437327
Income tax expense00(196)(42)(60)(76)(67)(14)(14)(56)
Net income6013440619129436922018023271
EPS — basic$0.54$1.25$3.92$1.55$2.21$3.24$3.07$2.75$0.37$4.02
EPS — diluted$0.53$1.17$3.53$1.43$2.02$2.87$2.37$2.20$0.36$3.30
Shares outstanding — basic (M)1101071011011018270656367
Shares outstanding — diluted (M)1231201131131149495877485

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.